Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interferon Beta-1b and Tacrolimus in Multiple Sclerosis
NCT00298662Phase 2Unknown
- Sponsor
- Clinique Neuro-Outaouais
- Start
- Feb 2003
- Modality
- Cytokines & Interferons, RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of interferon beta-1b and tacrolimus in multiple sclerosis (MS), sponsored by Clinique Neuro-Outaouais. Primary endpoints: Safety and Tolerability, Relapse Rate and 3 more. Status: unknown.
02
Drugs
interferon beta-1btacrolimus
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT00298662.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00298662.